Exzeo: Growth Decelerated, But This Cash Machine Is Too Cheap at 11x EBITDA — Buy

Exzeo (NYSE: XZO) has been beaten down all year. The stock is off roughly 33% year-to-date, down from a 52-week high of $24.60 to about $16 today. The market has taken a position: Exzeo's explosive growth phase is over, and the valuation should reflect a dramatically lower-growth business.

That conclusion is half-right. The growth has decelerated, and the market is right to demand proof that it doesn't decelerate further. But the valuation reset has gone further than the business deserves. Exzeo prints free cash flow at a 47% margin, carries no net debt, and has just guided to a massive seasonal Q3 ramp. At 11 times EV/EBITDA, this is a cash machine trading at a multiple more appropriate for a cyclical manufacturer than a profitable insurance technology platform.

I'm rating this a Buy.

What Changed

To understand the selloff, you need the before picture. In fiscal 2025, Exzeo was one of the fastest-growing names in insurance technology. Revenue jumped 62% to $217 million. Managed premium — the total amount of insurance premium flowing through Exzeo's platform for carrier partners — exploded 139% to $1.39 billion. The stock rallied hard on that trajectory.

Then Q1 2026 arrived, and the numbers stepped off a cliff. Revenue grew just 9% year-over-year. Managed premium growth slowed to 12%. The stock fell 19% in a single session on the earnings print, even though EPS beat estimates at $0.22 versus a $0.21 consensus.

Q2 2026, reported after market close today, continued the pattern. Revenue came in at $54.2 million versus a consensus estimate of roughly $55.7 million — a miss. EPS came in at $0.26, beating the $0.25 estimate. The top-line slowdown persists.

The deceleration is real. Exzeo's Insurance-as-a-Service platform, which provides end-to-end underwriting, claims, and policy administration tools to property and casualty carriers — primarily in the homeowners insurance market, with heavy Florida exposure — has moved from hyper-growth to a much more moderate pace.

The question is whether the market has priced in a business deterioration that is worse than what actually happened.

The Operating Picture Is Still Exceptional

Here's what the selloff has obscured. Even at this slower growth rate, Exzeo's profitability is extraordinary.

• EBITDA margin: 50%. That means for every dollar of revenue, 50 cents flows to operating cash earnings. Few technology platforms, SaaS or otherwise, sustain margins at that level.
• Free cash flow margin: 47%. Exzeo generated $103.6 million in trailing free cash flow, which represents the cash available after all operating expenses and capital expenditures. That is almost half of its trailing revenue.
• ROIC: 57%. Return on invested capital at this level suggests Exzeo is deploying carrier capital and its own balance sheet with extreme efficiency.
• Balance sheet: $231 million in cash, $105 million in debt, zero net debt burden. The company is not stretched. It doesn't need to raise capital. It has optionality.

The growth has slowed from 62% to single digits on a year-over-year basis. That matters. But the margins that matter for cash generation haven't collapsed. They've stayed where they were.

The Seasonal Catalyst

The most important near-term piece of context is Exzeo's seasonality and Q3 guidance. The company has set expectations for Q3 revenue of $73.25 million and EPS of $0.31.

That Q3 revenue figure is 35% higher than Q2's $54.2 million and represents the peak of the homeowners insurance season, when carriers renew and price policies ahead of hurricane season. Exzeo's Florida-heavy book makes it particularly sensitive to this cycle. Q3 is the quarter that proves whether the platform still commands meaningful pricing power with carriers.

If Exzeo hits that $73 million revenue mark, it would imply an annualized rate well above the $235 million full-year 2026 consensus. More importantly, it would show the market that the growth slowdown was a first-half phenomenon, not a structural break.

The catalyst clock is set. Q3 closes September 30th. The results will come out late October or early November. That's five weeks away.

Valuation: The Reset Outpaced The Deterioration

This is where the case crystallizes. Let's put the multiples in context.

Exzeo trades at 11.3 times trailing EV/EBITDA. For a company with 50% EBITDA margins and 47% free cash flow margins, that is low. Profitable SaaS and technology platforms of this size typically command 15–20 times EV/EBITDA even in their "growth slowing" phases. Exzeo is trading at a multiple more consistent with a mid-cycle industrial business than a software platform that converts half its revenue to free cash.

The trailing P/E of 17.4x is similarly unremarkable. For a company printing $103 million in trailing free cash flow on a $1.48 billion market cap, the free cash flow yield is roughly 7%. That means an investor buying at current prices receives 7 cents in free cash for every dollar invested, annually. Most dividend stocks don't offer that yield, and they carry the obligation to pay it out rather than reinvest it.

That tells you something: analysts expect margin leverage to continue even if the top line softens.

That's a wide implied gap, and it exists because Exzeo trades far below where even cautious analysts believe its cash flow and margins should value it.

The growth has slowed. I'm not minimizing that. But the valuation has fallen faster than the business. That's the classic setup for a buy-the-dip call: the multiple has done the work of pricing in a much worse outcome than the one that's materializing.

Risks

This isn't a risk-free trade. Three factors could reverse the setup.

Growth continues to decelerate. If managed premium growth stalls or turns negative, the platform thesis deteriorates. Exzeo's value proposition depends on scale: more premium through the platform means more data, better underwriting, and deeper carrier lock-in. Stagnation breaks that cycle.

Florida insurance dynamics worsen. Exzeo is heavily concentrated in Florida homeowners insurance. If the Florida market sees carrier exits, rate compression, or regulatory pressure that reduces the number of policies flowing through Exzeo's platform, the Q3 seasonal ramp could disappoint. Some Florida homeowners insurance rates have begun to ease in 2026, which is stabilizing for the consumer but could mean less urgency for carriers to use Exzeo's pricing and underwriting tools.

Concentration risk. A small number of carrier partners account for a disproportionate share of managed premium. Losing a major partner, or seeing one diversify away from Exzeo's platform, would be a structural blow.

The Verdict

Exzeo is not the 60%-growth story it was at the start of 2025. The deceleration from triple-digit managed premium growth to single-digit revenue growth is a material change that the market was right to price in.

But the market priced in a broken business, not a slower one. Exzeo still generates free cash flow at 47% of revenue, carries a fortress balance sheet with $231 million in cash and no net debt, and is guiding to a Q3 revenue number that implies a meaningful seasonal rebound. At 11 times EV/EBITDA, the stock offers room for the growth story to stabilize without requiring a multiple expansion bet.

The Q3 results in late October are the proof point. If Exzeo hits or exceeds that $73 million revenue target, the case strengthens into a high-conviction Buy. If it misses badly, I'd narrow the position.

At $16, with the downside buffered by $103 million in trailing free cash flow and the upside tied to a seasonal quarter that's already priced into guidance, the risk/reward favors buying. The valuation has reset faster than the business deteriorated. That's the exact setup this framework is built to identify.

Rating: Buy.

Key metric to watch: Q3 revenue versus the $73.25 million consensus, and whether managed premium growth reaccelerates from the 12% Q1 pace.

What would change the rating to Hold or Sell: A Q3 revenue miss below $65 million, a material carrier partner loss, or evidence that Florida homeowners insurance dynamics are structurally shrinking Exzeo's addressable market.